Forwards
Contracts to transact at specified future terms. Key considerations include counterparty exposure, market movement and documentation.
DERIVATIVES · RISK · REGULATION · COMPLIANCE
Derivatives through a RegTech lens.
Financial derivatives connect markets, treasury, risk, accounting, governance and regulatory controls. This page provides a structured reference for understanding forwards, futures, options, swaps and related exposures through risk, compliance, reporting and audit-readiness perspectives.
01 · FUNDAMENTALS
What are derivatives?
A derivative is a financial contract whose value changes in response to an underlying asset, rate, index, price, credit characteristic or other reference factor. Derivatives can support legitimate hedging and risk-management objectives, but can also introduce or transfer significant risks.
Futures
Standardised exchange-traded contracts. Margin, leverage, market risk and clearing arrangements are important considerations.
Options
Contracts providing a right, generally without an obligation, to transact under specified terms. Premium, volatility and valuation are key considerations.
Swaps
Contracts exchanging specified cash flows, including interest-rate and currency exposures. Valuation, counterparty and liquidity risks matter.
Credit derivatives
Instruments used to transfer or manage credit exposure, subject to applicable regulatory, legal and risk requirements.
OTC vs exchange-traded
OTC transactions may require additional attention to bilateral documentation, collateral, reporting, netting and counterparty risk.
02 · INSTITUTIONAL USE
Why banks and businesses use derivatives
Hedging
- Foreign exchange risk
- Interest-rate risk
- Commodity-price risk
- Certain credit exposures
Treasury management
Derivatives may be used to manage funding costs, currency exposure, interest-rate exposure and other balance-sheet risks.
Risk transfer
A derivative can transfer or redistribute an economic risk between counterparties. A reduction in one risk can introduce another.
03 · RISK MAP
Key derivatives risks
Market risk
Changes in interest rates, FX rates, commodity prices, equity prices, volatility or other market factors can change derivative values.
Counterparty credit risk
A counterparty may default while the transaction has positive value. Exposure measurement, limits, netting and collateral are key controls.
CVA risk
Changes in counterparty credit quality and relevant market factors can affect credit valuation adjustments.
Liquidity risk
Margin calls, collateral requirements, funding pressure and difficulty exiting positions can create liquidity stress.
Operational risk
Trade capture, lifecycle processing, settlement, reconciliation and data-quality failures can create material exposure.
Legal & model risk
Contract enforceability, netting, collateral terms, pricing models, assumptions and market data require effective governance.
04 · REGULATORY LANDSCAPE
Derivatives regulation by jurisdiction
Requirements vary by jurisdiction, product, counterparty, trading venue, clearing status and transaction type. Always verify current primary-source requirements before operational use.
Bangladesh
Bangladesh Bank's derivatives guidance addresses permitted derivatives, underlying exposure, hedging, risk management, suitability/appropriateness, documentation, reporting and approval conditions. The framework is particularly relevant to AD banks and eligible users.
Bangladesh Bank Derivatives Guideline ↗Basel / BCBS
Relevant Basel areas include counterparty credit risk, SA-CCR, CVA risk, market risk, capital requirements and related disclosure and risk-management expectations.
Basel Framework ↗European Union
EMIR addresses OTC derivatives, central counterparties and trade repositories, including reporting, clearing and risk-mitigation requirements. MiFID II/MiFIR may also be relevant depending on the activity.
European Commission — EMIR ↗United States
The US framework includes Dodd-Frank reforms and CFTC requirements covering areas such as swap reporting, clearing, execution, business conduct, record keeping and risk management, subject to applicability.
CFTC — Dodd-Frank ↗Regulatory boundary: A framework listed here does not mean every requirement applies to every institution or transaction. Applicability must be determined from the current primary source, entity status, product, jurisdiction and transaction facts.
05 · REPORTING & DATA
Derivatives reporting and data governance
Regulatory reporting should be treated as a controlled data lifecycle rather than a submission-only activity.
Trade Capture
Validation
Identifiers
Reporting
Reconciliation
Exception & Evidence
Data concepts
- LEI
- UTI
- UPI
- Counterparty data
- Product classification
- Valuation and collateral
- Lifecycle events
Data-quality controls
- Completeness
- Accuracy
- Timeliness
- Consistency
- Uniqueness
- Reconciliation
Exception management
Exceptions should be traceable from identification through investigation, correction, approval, resubmission where applicable and evidence retention.
06 · MARGIN & COLLATERAL
Margin and collateral management
Initial Margin
Designed to address potential future exposure over the relevant close-out period under the applicable framework.
Variation Margin
Generally reflects changes in current transaction or portfolio value and the applicable collateral arrangements.
Collateral controls
Eligibility, valuation, haircuts, margin calls, disputes, settlement, reconciliation and concentration monitoring may require dedicated controls.
07 · IFRS 9
Derivatives and accounting
Derivatives may have important accounting implications, including fair-value measurement and hedge-accounting requirements. Relevant areas include FVTPL, cash-flow hedges, fair-value hedges, documentation, effectiveness and disclosure. Accounting treatment should be determined under the applicable accounting framework and approved accounting policies.
08 · FINANCIAL CRIME
AML/CFT and sanctions considerations
Derivatives are not inherently suspicious. Institutions should assess whether activity is consistent with the customer's business, risk profile and underlying economic rationale.
Potential review indicators
- Unexplained complex structures
- Unusual counterparties
- Rapid or repeated termination/rebooking
- Unusual collateral movements
- Unexplained economic exposure
- Potential market-manipulation patterns
Control chain
KYC/CDD → Beneficial Ownership → Sanctions Screening → Transaction Monitoring → Counterparty Risk → Escalation → Investigation → Record Keeping
Red-flag boundary
A red flag is an indicator requiring further review. It is not, by itself, proof of money laundering, sanctions evasion, market abuse or other misconduct.
09 · GOVERNANCE & CONTROL
Derivatives control lifecycle
Product Approval
Counterparty
Underlying Exposure
Execution & Confirmation
Valuation
Margin / Collateral
Reporting
Monitoring
Reconciliation
Exceptions
Evidence
Assurance
Three Lines of Defense
First line: Treasury, Trading, Operations.
Second line: Market Risk, Counterparty Risk, Compliance, Model/Operational Risk.
Third line: Internal Audit.
Board & senior management
Oversight should address risk appetite, product approval, limits, material exposures, new products, stress scenarios, regulatory compliance and significant exceptions.
Audit methodology
DISCOVER → INSPECT → VERIFY → TEST → CHALLENGE → ASSESS → RISK-RATE → REMEDIATE → RETEST → ASSURE
10 · AUDIT CHECKLIST
Practical derivatives control review
| Control area | Key review question |
|---|---|
| Product approval | Is the product approved under the institution's governance framework? |
| Regulatory permission | Is any regulatory approval, permission or condition applicable? |
| Underlying exposure | Is the underlying exposure identifiable, genuine and evidenced where required? |
| Counterparty | Has counterparty credit risk and eligibility been assessed? |
| Limits | Is exposure within approved limits? |
| Valuation | Is valuation reliable and independently challenged where appropriate? |
| Margin / collateral | Are margin and collateral requirements monitored and reconciled? |
| Reporting | Are regulatory reports complete, accurate, timely and traceable? |
| AML/CFT & sanctions | Are applicable financial-crime and sanctions controls operating? |
| Governance | Is management/Board oversight evidenced? |
| Audit trail | Can key decisions, exceptions and remediation actions be evidenced? |
11 · AI & REGTECH
How AI and RegTech can support derivatives compliance
Regulatory intelligence
- Regulatory-change monitoring
- Obligation identification
- Regulatory-impact analysis
- Jurisdiction comparison
Compliance operations
- Exception detection
- Reporting-quality checks
- Policy/control mapping
- Documentation review
- Evidence management
Risk analytics
- Exposure monitoring
- Counterparty-risk indicators
- Anomaly detection
- Scenario analysis
- Limit monitoring
Responsible-AI boundary: AI-generated analysis should be treated as decision support unless the relevant production system has been separately validated, governed and approved. AI does not replace applicable law, regulatory interpretation, legal advice, approved institutional policy or human accountability.
12 · PRACTICAL CASES
From exposure to evidence
FX exposure
Commercial exposure → FX risk → permitted hedge → trade → valuation → monitoring → reporting → evidence.
Interest-rate exposure
Floating-rate liability → interest-rate risk → appropriate derivative → counterparty assessment → valuation → monitoring.
Commodity exposure
Import exposure → commodity-price risk → eligible hedge → underlying-document verification → margin/collateral → monitoring.
Control failure
Incorrect trade capture → incorrect exposure → reporting discrepancy → reconciliation exception → investigation → remediation → retest.
13 · REGTECH NEXUS CONNECTIONS
Derivatives within the RegTech ecosystem
The regulatory-control chain can be viewed as:
Regulation → Obligation → Policy → Control → Data → Monitoring → Evidence → Assurance
14 · REGULATORY SIGNALS
Derivatives regulatory updates
This section is designed for periodic addition of selected developments from authoritative sources.
| Date | Jurisdiction | Authority | Development | Control consideration |
|---|---|---|---|---|
| Periodic update | Bangladesh | Bangladesh Bank | Derivatives and commodity-price hedging guidance | Verify applicable product, underlying exposure, eligibility, approval and reporting conditions against the current primary source. |
| Periodic update | Global | BCBS / BIS | Basel derivatives and counterparty-risk framework | Assess applicable exposure, capital, risk-management and disclosure requirements. |
| Periodic update | EU / US | Relevant authorities | Derivatives reporting, clearing, margin and conduct developments | Determine jurisdictional and entity-level applicability before operational implementation. |
Important notice: This page is provided for educational, research and regulatory-intelligence purposes. It does not constitute legal, accounting, investment or regulatory advice and does not replace applicable law, regulatory instructions, approved institutional policies or professional judgment. Requirements may vary by jurisdiction, product, counterparty, transaction type and regulatory status. RegTech Nexus AI is an independent regulatory-intelligence and knowledge platform and should not be interpreted as an official regulator, supervisory authority or regulatory endorsement.